Hereditary Hemochromatosis (C282Y Mutation): Symptoms, Diagnosis & Treatment

Hereditary hemochromatosis (HH) is an autosomal recessive disorder of iron overload, most commonly caused by the C282Y mutation in the HFE gene (chr6). Homozygosity (two mutated copies) confers high penetrance; compound heterozygosity (C282Y/H63D) carries lower risk.

Pathophysiology

Mutant HFE protein disrupts hepcidin regulation → uncontrolled ferroportin-mediated iron export from enterocytes and macrophages → progressive iron deposition in parenchyma (liver, heart, pancreas, joints, skin, gonads, pituitary).

Clinical Manifestations

Symptoms typically appear after age 40 in men, post-menopause in women (iron loss via menstruation delays onset). Organ-specific effects:

  • General: Fatigue, weakness, lethargy
  • Joints: Arthralgia (2nd/3rd MCP joints characteristic), chondrocalcinosis
  • Abdominal: Hepatomegaly, right upper quadrant pain, cirrhosis, hepatocellular carcinoma risk ↑ 20-200x
  • Endocrine: Bronze diabetes (pancreatic β-cell damage + insulin resistance), hypogonadotropic hypogonadism (loss of libido, erectile dysfunction, amenorrhea), thyroid/adrenal insufficiency
  • Cardiac: Dilated/restrictive cardiomyopathy, arrhythmias, heart failure
  • Skin: Hyperpigmentation (bronze/gray), porphyria cutanea tarda
  • Neurologic: Rare; cognitive/mood changes

Diagnosis

  1. Iron studies: Elevated transferrin saturation (>45% fasting), elevated serum ferritin (>300 ng/mL men, >200 ng/mL women)
  2. Genetic testing: HFE C282Y homozygosity confirms diagnosis in appropriate biochemical context
  3. Liver biopsy / MRI (FerriScan): Quantify hepatic iron concentration; stage fibrosis

Treatment

  • Therapeutic phlebotomy: Weekly 500 mL until ferritin 50–100 ng/mL, then maintenance (3–4/year). First-line, highly effective.
  • Chelation (deferasirox/deferoxamine): For anemia, cardiac disease, or phlebotomy intolerance.
  • Dietary: Limit iron supplements, vitamin C with meals, alcohol (synergistic hepatotoxicity). No need for strict low-iron diet.
  • Organ-specific management: Diabetes, heart failure, hypogonadism per standard guidelines.

Key point: Early detection (family screening) and phlebotomy prevent irreversible organ damage. Normal life expectancy if treated pre-cirrhosis.

Genetic Disorders - Related Articles